TGF-beta as a T cell regulator in colitis and colon cancer

被引:80
作者
Becker, C [1 ]
Fantini, MC [1 ]
Neurath, MF [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Med, Lab Clin Immunol 1, D-55131 Mainz, Germany
关键词
TGF-beta; T cells; colitis; colon cancer;
D O I
10.1016/j.cytogfr.2005.09.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TGF-beta is a pleiotropic cytokine with powerful immunosuppressive functions. Mice deficient for TGF-beta 1 show a dramatic phenotype with severe multiorgan inflammation and die shortly after birth. Recent investigations have highlighted the role of TGF-beta in suppression of T cell mediated autoimmunne inflammation and anti-tumor immunity. In addition to its direct anti-inflammatory effects on T cells, TGF-beta has been implicated as central regulator of regulatory T cells. TGF-beta not only mediates the suppression of effector T cells by Tregs, recent evidence also reveals a role for TGF-beta along with TCR stimulation in the peripheral induction of regulatory T cells from naive CD4+CD25- cells. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 115 条
  • [1] T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells
    Afkarian, M
    Sedy, JR
    Yang, J
    Jacobson, NG
    Cereb, N
    Yang, SY
    Murphy, TL
    Murphy, KM
    [J]. NATURE IMMUNOLOGY, 2002, 3 (06) : 549 - 557
  • [2] CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
    Appleman, LJ
    van Puijenbroek, AAFL
    Shu, KM
    Nadler, LM
    Boussiotis, VA
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (06) : 2729 - 2736
  • [3] CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression
    Appleman, LJ
    Berezovskaya, A
    Grass, I
    Boussiotis, VA
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (01) : 144 - 151
  • [4] Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease
    Babyatsky, MW
    Rossiter, G
    Podolsky, DK
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : 975 - 984
  • [5] Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
    Bachmaier, K
    Krawczyk, C
    Kozieradzki, I
    Kong, YY
    Sasaki, T
    Oliveira-dos-Santos, A
    Mariathasan, S
    Bouchard, D
    Wakeham, A
    Itie, A
    Le, J
    Ohashi, PS
    Sarosi, I
    Nishina, H
    Lipkowitz, S
    Penninger, JM
    [J]. NATURE, 2000, 403 (6766) : 211 - 216
  • [6] Multiple forms of TGF-beta(1), in breast tissues: A biologically active form of the small latent complex of TGF-beta 1
    Baillie, R
    Coombes, RC
    Smith, J
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1566 - 1573
  • [7] TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
    Becker, C
    Fantini, MC
    Schramm, C
    Lehr, HA
    Wirtz, S
    Nikolaev, A
    Burg, J
    Strand, S
    Kiesslich, R
    Huber, S
    Ito, H
    Nishimoto, N
    Yoshizaki, K
    Nishimoto, N
    Galle, PR
    Blessing, M
    Rose-John, S
    Neurath, MF
    [J]. IMMUNITY, 2004, 21 (04) : 491 - 501
  • [8] Becker C, 2005, CELL CYCLE, V4, P217
  • [9] TRANSFORMING GROWTH-FACTOR-BETA AND CYCLOSPORINE-A INHIBIT THE INDUCIBLE ACTIVITY OF THE INTERLEUKIN-2 GENE IN T-CELLS THROUGH A NONCANONICAL OCTAMER-BINDING SITE
    BRABLETZ, T
    PFEUFFER, I
    SCHORR, E
    SIEBELT, F
    WIRTH, T
    SERFLING, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) : 1155 - 1162
  • [10] Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
    Chen, ML
    Pittet, MJ
    Gorelik, L
    Flavell, RA
    Weissleder, R
    von Boehmer, H
    Khazaie, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) : 419 - 424